Clinical Trial Update: LEO 90100 in the Treatment of Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 results for LEO 90100 in psoriasis vulgaris have been completed. The results were posted on 2015-12-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 90100

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2015-12-09